Evidence
Clin Nutr ESPEN. 2024 Apr;60:240-246. doi: 10.1016/j.clnesp.2024.02.013. Epub 2024 Feb 19.
ABSTRACT
BACKGROUND & AIMS: Cirrhosis is associated with insulin resistance and impaired glucose tolerance, which may be caused by impairments at different tissue levels (liver, skeletal muscle, and/or beta cell).
METHODS: Here, glucose kinetics at whole-body and skeletal muscle level in patients with cirrhosis (Child-Pugh A and B) were studied during parenteral nutrition using the isotope dilution technique and arteriovenous balance approach across the leg. As opposed to the euglycemic hyperinsulinemic clamp or glucose tolerance tests applied in previous studies, this approach provides a nutrient composition more similar to a normal meal while circumventing any possible portal-systemic shunting, impaired hepatic uptake and incretin effect.
RESULTS: We confirmed the presence of hepatic and peripheral insulin resistance in our patient population. Endogenous glucose production was less suppressed in response to parenteral nutrition. However, glucose uptake in skeletal muscle was increased.
CONCLUSION: Our results suggests that in our study participants with cirrhosis, the hepatic and peripheral insulin resistance is compensated for by increased insulin secretion and thus, increased glucose uptake in muscle. Hereby, glucose homeostasis is maintained.
PMID:38479917 | DOI:10.1016/j.clnesp.2024.02.013
Add to Google Keep
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Glucose turnover at whole-body and skeletal muscle level in response to parenteral nutrition in male patients with alcoholic liver cirrhosis
🌐 90 Days
VR Related Evidence Matrix
- Glucose turnover at whole-body and skeletal muscle level in response to parenteral nutrition in male patients with alcoholic liver cirrhosis
- Depletion of TBC1D4 improves the metabolic exercise response by overcoming genetically induced peripheral insulin resistance
- Drp1 controls complex II assembly and skeletal muscle metabolism by Sdhaf2 action on mitochondria
- Muscle fibre morphometric analysis (MusMA) correlates with muscle function and cardiovascular risk prognosis
- Clinical Overview of Sarcopenia, Frailty, and Malnutrition in Patients With Liver Cirrhosis
- Delineating the contribution of ageing and physical activity to changes in mitochondrial characteristics across the lifespan
- Fat loss and muscle gain: The possible role of cortical glutamate in determining the efficacy of physical exercise
- Assessment of sarcopenic obesity as a predictor of pneumonia in patients with stable schizophrenia-A prospective study
- Human umbilical cord mesenchymal stem cells attenuate diet-induced obesity and NASH-related fibrosis in mice
- MiR-18 regulates lipid metabolism of non-alcoholic fatty liver disease via IGF1
- Reduced exercise capacity occurs before intrinsic skeletal muscle dysfunction in experimental rat models of pulmonary hypertension
- Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus
- Inflammatory liver diseases and susceptibility to sepsis
- Effect of Zuogui Jiangtang Qinggan Formula on lipid metabolism in db/db mouse model of type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease
- Circadian desynchrony and glucose metabolism
- Hypercaloric low-carbohydrate high-fat diet protects against the development of nonalcoholic fatty liver disease in obese mice in contrast to isocaloric Western diet
- Three-Dimensional Structure of Novel Liver Cancer Biomarker Liver Cancer-Specific Serine Protease Inhibitor Kazal (LC-SPIK) and Its Performance in Clinical Diagnosis of Hepatocellular Carcinoma (HCC)
- Relationship between changes in blood glucose, glycosylated hemoglobin [HbA1c], cholesterol, and triglyceride and changes in hepatic enzymes
- Automated CT Analysis of Body Composition as a Frailty Biomarker in Abdominal Surgery
- Characteristics of nuclear architectural abnormalities of myotubes differentiated from LmnaH222P/H222P skeletal muscle cells
- Food perception promotes phosphorylation of MFFS131 and mitochondrial fragmentation in liver
- Abdominal CT metrics in 17,646 patients reveal associations between myopenia, myosteatosis, and medical phenotypes: a phenome-wide association study
- Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease
- Triglyceride Glucose Index is Associated with Ultrasonographic Fatty Liver Indicator in Children and Adolescents with Non-alcoholic Fatty Liver Disease
- Body composition assessment by artificial intelligence can be a predictive tool for short-term postoperative complications in Hartmann's reversals
- Xiaozhi Formula Attenuates Non-Alcoholic Fatty Liver Disease by Regulating Lipid Metabolism via Activation of AMPK and PPAR pathways
- Xiaozhi Formula Attenuates Non-Alcoholic Fatty Liver Disease by Regulating Lipid Metabolism via Activation of AMPK and PPAR pathways
- Incretin-based investigational therapies for the treatment of MASLD/MASH
- Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank
- Genetic correlations between liver fat content, metabolic health, and adiposity distribution in the Fels Longitudinal Study
- Effectiveness of different tools for malnutrition in the assessment of patients with cirrhosis
- Dietary pattern associated with non-alcoholic fatty liver disease (NAFLD) in non-diabetic adult patients: A case control study
- Dietary pattern associated with non-alcoholic fatty liver disease (NAFLD) in non-diabetic adult patients: A case control study
- Semaglutide combined with empagliflozin vs. monotherapy for non-alcoholic fatty liver disease in type 2 diabetes: Study protocol for a randomized clinical trial
- Role of Angiotensin II in Non-Alcoholic Steatosis Development
- Semaglutide alters gut microbiota and improves NAFLD in db/db mice
- Outcome of individuals with alcoholic cirrhosis hospitalized with first decompensation and their predictors
- The double roles of T cell-mediated immune response in the progression of MASLD
- Serum Vitamin D Level in Overweight Individuals and Its Correlation With the Incidence of Non-alcoholic Fatty Liver Disease
- Occult liver disease: a multinational perspective
- Malnutrition management and the application of medical nutrition therapy in hospitalized patients at the end of life
- White Adipose Tissue in Metabolic Associated Fatty Liver Disease
- Influence of glucagon-like peptide-1 receptor agonists on fat accumulation in patients with diabetes mellitus and non-alcoholic fatty liver disease or obesity: A systematic review and meta-analysis of randomized control trials
- Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbab le, gut-restricted adsorbent in models and patients with cirrhosis
- Deuterium metabolic imaging differentiates glioblastoma metabolic subtypes and detects early response to chemoradiotherapy
- Pulmonary Dysfunction in Patients with Cirrhosis of the Liver: A Study of Pulmonary Function Tests and Arterial Blood Gases
- Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease
- The protective effects of Ninjin'yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouse
- Hepatopancreatic metabolic disorders and their implications in the development of Alzheimer's disease and vascular dementia
- Liver cirrhosis in a patient with alcohol dependence and autoimmune hepatitis
- A modified rehabilitation paradigm bilaterally increased rat extensor digitorum communis muscle size but did not improve forelimb function after stroke
- Falsely low glycosylated haemoglobin levels probably secondary to hypersplenism in a patient with diabetes mellitus
- Amyloid-beta neuropathology induces bone loss in male mice by suppressing bone formation and enhancing bone resorption
- Comorbidity and multimorbidity in patients with cirrhosis, hospitalised in an internal medicine ward: a monocentric, cross-sectional study
- The Impact of Probiotic Bifidobacterium on Liver Diseases and the Microbiota
- Severe hypoglycemia with reduced liver volume as an indicator of end-stage malnutrition in patients with anorexia nervosa: a retrospective observational study
- Liver Lipidomics Analysis Revealed the Protective mechanism of Zuogui Jiangtang Qinggan Formula in type 2 diabetes mellitus with non-alcoholic fatty liver disease
- Liver Lipidomics Analysis Revealed the Protective mechanism of Zuogui Jiangtang Qinggan Formula in type 2 diabetes mellitus with non-alcoholic fatty liver disease
- Body composition impacts outcome of bronchoscopic lung volume reduction in patients with severe emphysema: a fully automated CT-based analysis
- Predicting Blood Glucose Levels with Organic Neuromorphic Micro-Networks
- Body Composition, Sarcopenic Obesity, and Cognitive Function in Older Adults: Findings From the National Health and Nutrition Examination Survey (NHANES) 1999-2002 and 2011-2014
- Precise cortical contributions to sensorimotor feedback control during reactive balance
- Impact of Transgenerational Nutrition on Nonalcoholic Fatty Liver Disease Development: Interplay between Gut Microbiota, Epigenetics and Immunity
- In Vitro to In Vivo Scalars for Drug Clearance in Non-Alcoholic Fatty Liver and Steatohepatitis
Evidence Blueprint
Glucose turnover at whole-body and skeletal muscle level in response to parenteral nutrition in male patients with alcoholic liver cirrhosis
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Glucose turnover at whole-body and skeletal muscle level in response to parenteral nutrition in male patients with alcoholic liver cirrhosis
🌐 365 Days
VR Related Evidence Matrix
- Glucose turnover at whole-body and skeletal muscle level in response to parenteral nutrition in male patients with alcoholic liver cirrhosis
- Skeletal muscle protein turnover responses to parenteral nutrition in patients with alcoholic liver cirrhosis and sarcopenia
- Skeletal Muscle Consequences of Phosphatidylethanolamine Synthesis Deficiency
- Fish oil minimizes feed intake and improves insulin sensitivity in Zucker fa/fa rats
- Myosteatosis for Early Detection of Muscle Disorder in Patients With Liver Cirrhosis
- Biochemical and functional characterization of skeletal muscle cells differentiated from tonsil-derived mesenchymal stem cells
- Interesterified palm oil promotes insulin resistance and altered insulin secretion and signaling in Swiss mice
- Depletion of TBC1D4 improves the metabolic exercise response by overcoming genetically induced peripheral insulin resistance
- Liver-derived extracellular vesicles improve whole-body glycaemic control via inter-organ communication
- Prevalence of and associated factors for sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis
- Alcohol blunts pregnancy-mediated insulin resistance and reduces fetal brain glucose despite elevated fetal gluconeogenesis, and these changes associate with fetal weight outcomes
- Pregnane X receptor activation remodels glucose metabolism to promote NAFLD development in obese mice
- Drp1 controls complex II assembly and skeletal muscle metabolism by Sdhaf2 action on mitochondria
- Sarcopenia in chronic liver diseases
- Deep RNA sequencing of muscle tissue reveals absence of viral signatures in dermatomyositis
- Muscle fibre morphometric analysis (MusMA) correlates with muscle function and cardiovascular risk prognosis
- Simple bedside tests of muscle strength and function correlate with computed tomography-skeletal muscle index for assessment of sarcopenia in cirrhosis
- Celastrol attenuates HFD-induced obesity and improves metabolic function independent of adiponectin signaling
- Pancreatic beta-cell specific BAG3 knockout results in chronic hyperinsulinemia inducing insulin resistance
- Clinical Overview of Sarcopenia, Frailty, and Malnutrition in Patients With Liver Cirrhosis
- Metabolic Health and Disease: A Role of Osteokines?
- Extracellular vesicles from obese and diabetic mouse plasma alter C2C12 myotube glucose uptake and gene expression
- Mitochondrial transplantation as a possible therapeutic option for sarcopenia
- Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis
- Delineating the contribution of ageing and physical activity to changes in mitochondrial characteristics across the lifespan
- In vivo heat production dynamics during a contraction-relaxation cycle in rat single skeletal muscle fibers
- Overexpression of lncRNA HEM2M alleviates liver injury in mice with non-alcoholic fatty liver disease
- Fat loss and muscle gain: The possible role of cortical glutamate in determining the efficacy of physical exercise
- Lithium and exercise ameliorate insulin-deficient hyperglycemia by independently attenuating pancreatic α-cell mass and hepatic gluconeogenesis
- Knockout of STE20-type kinase TAOK3 does not attenuate diet-induced NAFLD development in mice
- Assessment of sarcopenic obesity as a predictor of pneumonia in patients with stable schizophrenia-A prospective study
- Gremlin-1 in pregnancy and postpartum: relation to the fatty liver index, markers of bone health, glucose metabolism and gestational diabetes mellitus status
- Human umbilical cord mesenchymal stem cells attenuate diet-induced obesity and NASH-related fibrosis in mice
- MiR-18 regulates lipid metabolism of non-alcoholic fatty liver disease via IGF1
- Association between suicidal behavior and impaired glucose metabolism in first-episode drug-naïve patients with schizophrenia
- The impact of piperine on the metabolic conditions of patients with NAFLD and early cirrhosis: a randomized double-blind controlled trial
- Effects of intermittent fasting regimens on glycemic, hepatic, anthropometric, and clinical markers in patients with non-alcoholic fatty liver disease: Systematic review and meta-analysis of randomized controlled trials
- Eryngium billardieri extract affects cardiac gene expression of master regulators of cardiomyaopathy in rats with high fatdiet-induced insulin resistance
- Prevalence and impact on the outcome of myosteatosis in patients with cirrhosis: a systematic review and meta-analysis
- Reduced exercise capacity occurs before intrinsic skeletal muscle dysfunction in experimental rat models of pulmonary hypertension
- Loss of NOR-1 represses muscle metabolism through mTORC1-mediated signaling and mitochondrial gene expression in C2C12 myotubes
- Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus
- Sex- and reproductive status-specific relationships between body composition and non-alcoholic fatty liver disease
- Inflammatory liver diseases and susceptibility to sepsis
- The antianginal ranolazine fails to improve glycemia in obese liver-specific pyruvate dehydrogenase deficient male mice
- Prefrontal cortical dopamine deficit may cause impaired glucose metabolism in schizophrenia
- Effects of 8 weeks of resistance training in combination with a high protein diet on body composition, muscular performance, and markers of liver and kidney function in untrained older ex-military men
- LEAP2 is Associated with Cardiometabolic Markers, but is Unchanged by Antidiabetic Treatment in People with Prediabetes
- Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis
- Systematic review of sarcopenia in inflammatory bowel disease
- Ablation of the carboxy-terminal end of MAMDC2 causes a distinct muscular dystrophy
- Muscle Mass Adjusted for Body Weight Is Associated with Significant Liver Fibrosis in Young Adults with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study from a Korean Military Hospital
- Effect of Zuogui Jiangtang Qinggan Formula on lipid metabolism in db/db mouse model of type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease
- Circadian desynchrony and glucose metabolism
- Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis
- Hypercaloric low-carbohydrate high-fat diet protects against the development of nonalcoholic fatty liver disease in obese mice in contrast to isocaloric Western diet
- Why do some glucose-lowering agents improve non-alcoholic fatty liver disease whereas others do not? A narrative review in search of a unifying hypothesis
- Three-Dimensional Structure of Novel Liver Cancer Biomarker Liver Cancer-Specific Serine Protease Inhibitor Kazal (LC-SPIK) and Its Performance in Clinical Diagnosis of Hepatocellular Carcinoma (HCC)
- Corrected QT interval in cirrhosis: A systematic review and meta-analysis
- Relationship between changes in blood glucose, glycosylated hemoglobin [HbA1c], cholesterol, and triglyceride and changes in hepatic enzymes
- Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles
- Automated CT Analysis of Body Composition as a Frailty Biomarker in Abdominal Surgery
- Ceramide synthase 6 (CerS6) is upregulated in alcohol-associated liver disease and exhibits sex-based differences in the regulation of energy homeostasis and lipid droplet accumulation
- Characteristics of nuclear architectural abnormalities of myotubes differentiated from LmnaH222P/H222P skeletal muscle cells